Indonesian (IDX) Pharma Industry Analysis
UpdatedJan 30, 2023
DataAggregated Company Financials
Companies9
- 7D-0.7%
- 3M-1.3%
- 1Y4.9%
- YTD-0.8%
The Pharma industry has stayed flat over the last week. The past year has been better, since the industry has gained 4.9% in that time. As for the next few years, earnings are expected to grow by 12% per annum.
Industry Valuation and Performance
Has the Indonesian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 30 Jan 2023 | Rp122.8t | Rp65.0t | Rp4.6t | 22x | 26.6x | 1.9x |
| Wed, 28 Dec 2022 | Rp121.7t | Rp65.0t | Rp4.6t | 21.2x | 26.3x | 1.9x |
| Fri, 25 Nov 2022 | Rp125.4t | Rp65.2t | Rp4.4t | 28.3x | 28.2x | 1.9x |
| Sun, 23 Oct 2022 | Rp121.2t | Rp66.0t | Rp4.9t | 22x | 24.9x | 1.8x |
| Tue, 20 Sep 2022 | Rp117.7t | Rp67.1t | Rp5.1t | 20.6x | 23x | 1.8x |
| Thu, 18 Aug 2022 | Rp107.2t | Rp67.1t | Rp5.1t | 16.1x | 20.8x | 1.6x |
| Sat, 16 Jul 2022 | Rp111.7t | Rp66.7t | Rp5.2t | 13.8x | 21.4x | 1.7x |
| Mon, 13 Jun 2022 | Rp107.3t | Rp66.6t | Rp5.2t | 14x | 20.5x | 1.6x |
| Wed, 11 May 2022 | Rp107.6t | Rp65.8t | Rp5.3t | 20.9x | 20.5x | 1.6x |
| Fri, 08 Apr 2022 | Rp108.8t | Rp64.3t | Rp5.3t | 23.3x | 20.6x | 1.7x |
| Sun, 06 Mar 2022 | Rp115.5t | Rp63.2t | Rp5.1t | 24.4x | 22.6x | 1.8x |
| Tue, 01 Feb 2022 | Rp116.8t | Rp63.2t | Rp5.1t | 24.7x | 22.8x | 1.8x |
| Thu, 30 Dec 2021 | Rp117.3t | Rp63.1t | Rp5.1t | 24.6x | 22.8x | 1.9x |
| Sat, 27 Nov 2021 | Rp116.3t | Rp60.3t | Rp4.4t | 24.9x | 26.2x | 1.9x |
| Mon, 25 Oct 2021 | Rp107.7t | Rp58.6t | Rp4.3t | 20.3x | 25x | 1.8x |
| Wed, 22 Sep 2021 | Rp105.2t | Rp57.5t | Rp4.3t | 22.7x | 24.7x | 1.8x |
| Fri, 20 Aug 2021 | Rp99.4t | Rp57.5t | Rp4.3t | 21.4x | 23.4x | 1.7x |
| Fri, 04 Jun 2021 | Rp107.9t | Rp56.1t | Rp4.1t | 21.8x | 26x | 1.9x |
| Mon, 08 Mar 2021 | Rp117.2t | Rp55.7t | Rp4.0t | 23.8x | 29.2x | 2.1x |
| Thu, 10 Dec 2020 | Rp116.0t | Rp54.4t | Rp3.9t | 18.6x | 30x | 2.1x |
| Wed, 02 Sep 2020 | Rp112.5t | Rp48.8t | Rp3.7t | 16.5x | 30.5x | 2.3x |
| Sat, 06 Jun 2020 | Rp85.8t | Rp49.5t | Rp3.6t | 12.6x | 23.8x | 1.7x |
| Tue, 10 Mar 2020 | Rp71.5t | Rp48.3t | Rp3.5t | 10.8x | 20.6x | 1.5x |
Price to Earnings Ratio
24.6x
Current Industry PE
- Investors are relatively neutral on the Indonesian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 25.1x.
- The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 10% per year over the last three years.
- Revenues for these companies have grown 10% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indonesian Healthcare industry?
| ID Market | 0.45% | |
| Healthcare | -1.17% | |
| Pharma | -0.70% | |
| Pharma | -0.70% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MERK Merck | Rp4.85k | 0.2% +Rp4.5b | 29.3% | PE13.3x | |
| PEHA Phapros | Rp695.00 | 0.7% +Rp4.2b | -37.4% | PE33.7x |